Luca Monzo

🇮🇹🇫🇷 | Heart Failure Specialist @CHRU_de_Nancy | Researcher @CiCPNancy | @UniLorraine | #FESC

[Guillaume Baudry @GuiBaudry]

🌍 Excited to share our publication led by @hvanspall exploring the consistency of HFrEF treatments in underrepresented groups in RCTs .

- No heterogeneity across groups
- Need for inclusive RCTs

#HeartFailure #HealthEquity #ClinicalTrials

https://t.co/aeKZnD9TfB

[CIC-Plurithématique Nancy @CiCPNancy]

Association of ventricular–arterial coupling with biomarkers involved in heart failure pathophysiology – the STANISLAS cohort @NicolasGirerd @LucaMonzo @GuiBaudry @FaiezZANNAD @FCRIN_network @INICRCT @ESC_Journals #cardiovascular
https://t.co/3d5vzxlkuC

[CIC-Plurithématique Nancy @CiCPNancy]

Decoding proteins in cardiometabolic disease: the power and challenges of proteomics @NicolasGirerd @LucaMonzo @Heart_BMJ
https://t.co/MSdp3nMVJF

[Luca Monzo @LucaMonzo]

Increased β-OHB seems to reflect the heightened lipolytic state induced by neurohormonal overdrive in advanced HFrEF, and not a rescue mechanism to improve energetics as previously proposed.
https://t.co/yQoQwFUP0W
@CiCPNancy @EJHFEiC @ESC_Journals @Univ_Lorraine @MayoClinic

[CIC-Plurithématique Nancy @CiCPNancy]

Hypothermia in patients with cardiac arrest prior to ECMO-VA: Insight from the HYPO-ECMO trial - @NicolasGirerd @GuiBaudry @LucaMonzo @ResusJournal
https://t.co/1hbnxiQh4c

[HFAPresident @HFA_President]

🧡🧡 #HeartFailureAwarenessDays 2024 🧡🧡

It's happening now, from 29 April to 5 May.

It is our duty to advocate for early symptom recognition, accurate diagnosis, & effective treatment.

Detect the undetected: FIND ME

Thank you to the @escardio community and all #ESC_HFA National #HeartFailure Societies and WG for joining this campaign

Find out more https://t.co/9eQ6zsrXfT

#HFA_ESC #20yearsHFA #HeartFailure2024

[CIC-Plurithématique Nancy @CiCPNancy]

Use of the Win Ratio Analysis in Critical Care Trials
@LucaMonzo @GuiBaudry @NicolasGirerd @INICRCT @CHRU_de_Nancy @atscommunity @Univ_Lorraine @InsermEst | #Cardiology #CardioTwitter #HeartFailure #ClinicalTrials
https://t.co/QZ6mbBI5Fs

[CIC-Plurithématique Nancy @CiCPNancy]

Pressure overload is associated with right ventricular dyssynchrony in heart failure with reduced ejection fraction @LucaMonzo @ESC_Journals
https://t.co/MBoF9jzaAZ

[CIC-Plurithématique Nancy @CiCPNancy]

Tackling the ReD(S) Flag of Congestion in Heart Failure
@NicolasGirerd @LucaMonzo @INICRCT @Univ_Lorraine |#Cardiology #Cardiotwitter
https://t.co/ZZJJDvhnvi

[CIC-Plurithématique Nancy @CiCPNancy]

Use of the Win Ratio Analysis in Critical Care Trials
https://t.co/QZ6mbBI5Fs @LucaMonzo @GuiBaudry @NicolasGirerd @ATSBlueEditor #Cardiotwitter

[Luca Monzo @LucaMonzo]

New in @ESC_Journals our research on RV dyssynchrony (RVD) in advanced HFrEF:

- Main determinant of RVD is RVEF
- Strong link between RVD and increased clinical risk
- Sildenafil acutely improves RVD reducing afterload

https://t.co/QPQPMx6LAO
@CiCPNancy @ikemcz

[Luca Monzo @LucaMonzo]

New insights from COMMANDER-HF trial: Plasma D-dimer best predictive tool for stroke risk among HFrEF patients with sinus rhythm and recent HF hospitalization. Low-dose rivaroxaban lowers risk in high d-dimer group https://t.co/HmOGufwWIS @NicolasGirerd @CiCPNancy @FaiezZANNAD

[Luca Monzo @LucaMonzo]

Best lessons learned at @CVCTForum keynote lecture by Milton Packer @GuiBaudry @_antocannata @GianluSava @WilfriedMullens @NicolasGirerd

[Nicolas Girerd @NicolasGirerd]

Happy that the REMI study was finally published in EJHF ! Bravo to @LucaMonzo for this achievement. Let’s hear him give us a fresh look on aldosterone in post MI remodeling
@SABOURETCardio @Giccardio_fr @EJHFEiC

[EJHF Editor-in-Chief @EJHFEiC]

The role of #MRA in post-MI remodelling. Interrupting a vicious cycle across the entire LVEF spectrum.

https://t.co/vFSYzeCeNI

@HFA_President @_antocannata @escardio @ESC_Journals @HanCardiomd @DjawidHashemi @MarcoMetra @GianluSava @gbiondizoccai @ESC_Lavinia @LucaMonzo

[CIC-Plurithématique Nancy @CiCPNancy]

Dr. @LucaMonzo, cardiologist at CIC-P in Nancy, discuss about the REMI study. Aldosterone after MI associated with adverse LV remodelling in the mid-term (not long), even in the subgroup with LVEF >40% @NicolasGirerd @FaiezZANNAD @Univ_Lorraine @GuiBaudry
https://t.co/6Q6VTSf7U0

[Wilfried Mullens @WilfriedMullens]

Top-notch science, interactivity, scientific collaboration, mentorship, live long friendship and so much more.....

[Luca Monzo @LucaMonzo]

69% di borse di specializzazione MEU non assegnate #SSM23. I politici continuino a guardare il dito (numero chiuso) e non la luna (stipendi, protezione dalle aggressioni, sistema panpenalistico). @VincenzoDeLuca @GiorgiaMeloni

https://t.co/SBulLxtsdP

[Guillaume Baudry @GuiBaudry]

Do you know the ESC guidelines on advanced heart failure well?
Take 10 min to answer the HFA/ESC survey.
https://t.co/J5RHuTNYN2

@escardio @FinnGustafsson @NicolasGirerd @HFA_President @WilfriedMullens @JeroenDauw @CCF_cardio @Giccardio_fr @CNCHcollege @SFCardio #ESCCongress

[Mamas A. Mamas @mmamas1973]

Any junior doctor / medical student that leads a project in my group/ writes it = first author. Any junior doctor that contributes to a Projects but doesn't lead it = authorship. Don't work with anyone who doesn't offer this.

Don't accept anything else- irrespective of what people may tell you. If you don't value yourself / efforts no one else will.